• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Zogenix, Inc. (ZGNX)

    -NasdaqGM
    1.68 Up 0.03(1.82%) Feb 27, 4:00PM EST
    |After Hours : 1.67 Down 0.01 (0.30%) Feb 27, 4:36PM EST
    Add to Portfolio
    Prev Close:1.65
    Open:1.66
    Bid:1.65 x 2000
    Ask:N/A
    1y Target Est:2.75
    Beta:0.89
    Next Earnings Date:N/A
    Day's Range:1.62 - 1.70
    52wk Range:1.07 - 4.68
    Volume:2,883,891
    Avg Vol (3m):2,592,160
    Market Cap:257.11M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ZGNXUp 1.82%257.11M
    AZNDown 0.16%87.02B
    GSKDown 0.88%114.07B
    PFEDown 0.78%216.24B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):7.10
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.65
    Quarterly EPS Est (Dec-14) :-0.11
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):-0.10

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders and pain. The company’s commercial product includes Zohydro, a single-entity extended-release hydrocodone for... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback